US Stem Cell Inc (USRM)

[4toSchool]

I agree.

I still don't fully understand why Tomas was so intent on working within the FDA's RMAT program, then he ceased pursuing it until the FDA released better guidelines, then $USRM pivoted completely away from the FDA, and Comella's been in the FDA'S face ever since. I don't get it. Why didn't they pursue the RMAT program again once the FDA released the guidelines, which is what I thought was Tomas' strategy?